Department of Chemistry , NC State University , Raleigh , North Carolina 27695 , United States.
Comparative Medicine Institute , NC State University , Raleigh , North Carolina 27695 , United States.
J Am Chem Soc. 2019 Feb 6;141(5):1961-1969. doi: 10.1021/jacs.8b10521. Epub 2019 Jan 24.
There is significant interest in diversifying the structures of polyketides to create new analogues of these bioactive molecules. This has traditionally been done by focusing on engineering the acyltransferase (AT) domains of polyketide synthases (PKSs) responsible for the incorporation of malonyl-CoA extender units. Non-natural extender units have been utilized by engineered PKSs previously; however, most of the work to date has been accomplished with ATs that are either naturally promiscuous and/or located in terminal modules lacking downstream bottlenecks. These limitations have prevented the engineering of ATs with low native promiscuity and the study of any potential gatekeeping effects by domains downstream of an engineered AT. In an effort to address this gap in PKS engineering knowledge, the substrate preferences of the final two modules of the pikromycin PKS were compared for several non-natural extender units and through active site mutagenesis. This led to engineering of the methylmalonyl-CoA specificity of both modules and inversion of their selectivity to prefer consecutive non-natural derivatives. Analysis of the product distributions of these bimodular reactions revealed unexpected metabolites resulting from gatekeeping by the downstream ketoreductase and ketosynthase domains. Despite these new bottlenecks, AT engineering provided the first full-length polyketide products incorporating two non-natural extender units. Together, this combination of tandem AT engineering and the identification of previously poorly characterized bottlenecks provides a platform for future advancements in the field.
人们对使聚酮结构多样化以创造这些生物活性分子的新类似物非常感兴趣。这传统上是通过专注于工程化负责掺入丙二酰辅酶 A 延伸单元的聚酮合酶 (PKS) 的酰基转移酶 (AT) 结构域来实现的。以前已经使用工程 PKS 利用了非天然延伸单元;然而,迄今为止,大多数工作都是在天然混杂的 AT 或位于缺乏下游瓶颈的末端模块中完成的。这些限制阻止了低天然混杂性的 AT 的工程化以及对工程化 AT 下游结构域的任何潜在门控效应的研究。为了弥补这一 PKS 工程知识的空白,比较了 pikromycin PKS 的最后两个模块对几种非天然延伸单元的底物偏好,并通过活性位点诱变进行了研究。这导致了两个模块的甲基丙二酰辅酶 A 特异性的工程化,并反转了它们对连续非天然衍生物的选择性。对这些双模块反应的产物分布进行分析揭示了由下游酮还原酶和酮合酶结构域的门控作用产生的意想不到的代谢物。尽管存在这些新的瓶颈,AT 工程化还是提供了第一个包含两个非天然延伸单元的全长聚酮产物。总之,这种串联 AT 工程化和先前表征较差的瓶颈的鉴定相结合,为该领域的未来发展提供了一个平台。